Balanced news tone
News Sentiment
MARI sentiment intelligence
Marinomed Biotech AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-4.7% over one week, -13.7% over four weeks, trend inactive, and below fair value.
Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:10
- Source
- TradingView
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Marinomed Biotech AG historical stock prices at wienerborse.at/en
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2024 06:45
- Source
- Wiener Börse
Marinomed Biotech AG STOCK • Company Profile • ATMARINOMED6 • Vienna Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2024 06:43
- Source
- Wiener Börse
Marinomed Biotech AG stock price at wienerborse.at/en
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2024 06:13
- Source
- Wiener Börse